|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Technical Indicators||Sell||Strong Buy||Strong Buy||Neutral||Strong Buy|
|Summary||Sell||Strong Buy||Strong Buy||Neutral||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Doji Star Bearish||1H||Current|
|Advance Block Bearish||15||1||Dec 15, 2017 03:30PM|
|Engulfing Bearish||1H||5||Dec 15, 2017 10:00AM|
|Three Outside Up||1H||7||Dec 14, 2017 03:00PM|
|Tata Steel Ltd||703.00||709.35||674.00||+8.30||+1.19%||1.90M||05:09:44|
Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.Read More
|U.S. Commodity Futures Trading Commission (United States)||$250||Start Trading|
|U.S. Commodity Futures Trading Commission (United States)||Start Trading|
Add a Comment
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.